Profile
Dr. Eugene Zhukovsky is Chief Scientific Officer & Member-Management Board at Affimed Therapeutics AG and Chief Scientific Officer at Affimed NV.
Dr. Zhukovsky was previously employed as a Principal by Xencor, Inc.
He received his graduate degree from the St. Petersburg University of Economics & Finance and a doctorate degree from Brandeis University.
Former positions of Eugene Zhukovsky
| Companies | Position | End |
|---|---|---|
| AFFIMED N.V. | Chief Tech/Sci/R&D Officer | 2014-03-30 |
| XENCOR, INC. | Corporate Officer/Principal | 2008-12-31 |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Chief Tech/Sci/R&D Officer | - |
Training of Eugene Zhukovsky
| Brandeis University | Doctorate Degree |
| Saint Petersburg State University of Economics | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| XENCOR, INC. | Health Technology |
| AFFIMED N.V. | Health Technology |
| Private companies | 1 |
|---|---|
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
- Stock Market
- Insiders
- Eugene Zhukovsky
